仲瀬教授が関わっている多施設共同研究が、The Lancet Gastroenterology & Hepatologyに掲載されました

Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial

Taku Kobayashi, Satoshi Motoya, Shiro Nakamura, Takayuki Yamamoto, Masakazu Nagahori, Shinji Tanaka, Tadakazu Hisamatsu, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe, Takayuki Matsumoto, Masanori Tanaka, Takayuki Abe, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi, HAYABUSA Study Group

Lancet Gastroenterol Hepatol. 2021 Apr 19;S2468-1253(21)00062-5. doi: 10.1016/S2468-1253(21)00062-5.

PMID: 33887262  DOI: 10.1016/S2468-1253(21)00062-5